chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Hypokinesia, Nausea, Pain
Clinical narrative: Pain and reduced range of motion in arm that received injection.; Pain and reduced range of motion in arm that received injection; body ache; fatigue; joint pain; fever; naseau; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included allergic to coconut. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 09:00, the patient experienced pain and reduced range of motion in arm that received injection, body aches, fatigue, joint pain, fever, nausea. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain and reduced range of motion in arm that received injection, body aches, fatigue, joint pain, fever, nausea were not resolved.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Pain and reduced range of motion in arm that received injection.; Pain and reduced range of motion in arm that received injection; body ache; fatigue; joint pain; fever; naseau; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included allergic to coconut. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 09:00, the patient experienced pain and reduced range of motion in arm that received injection, body aches, fatigue, joint pain, fever, nausea. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain and reduced range of motion in arm that received injection, body aches, fatigue, joint pain, fever, nausea were not resolved.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Severe chills; Body aches; Fever of 100.7; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6204) via an unspecified route of administration in the left arm on 07Mar2021 at 12:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Feb2021 at 12:00(at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021 at 01:00, the patient experienced severe chills, body aches and fever of 100.7. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On 15Mar2021, the patient underwent test of body temperature and tested with a temperature of 100.7(unspecified unit). The clinical outcome of the events severe chills, body aches and fever of 100.7 were resolved on an unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphocele
Clinical narrative: Tender and sore under arm; Dime/quarter sized lymph cyst under right arm; This is a spontaneous report from a contactable other healthcare professional, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 10:30 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and minerals nos, vitamins nos (PRENATAL VITAMINS); both for unspecified indication from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Mar2021 at 10:15 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. The patient previously took sulfamethoxazole;trimethoprim (SEPTRA) for unspecified indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:30, at 2 days post 2nd vaccine, the patient experienced dime/quarter sized lymph cyst under right arm and tender and sore under arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the event dime/quarter sized lymph cyst under right arm and tender and sore under arm was unknown at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity, Pyrexia, Rash
Clinical narrative: Fever; Arm pain; Headache; Chills; Rash from site to hairline; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729) via an unspecified route of administration in the right arm on 08Apr2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunization. Medical history included celiac disease. The patient previously took penicillin and experienced penicillin allergy. Other medication taken within two weeks prior to vaccination included FemCon from unknown date for unknown indication. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the right arm on 18Mar2021 at 16:15 (at the age of 32-years-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 01:00 the patient experienced fever, arm pain, headache, chills, rash from site to her hairline. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Benadryl. The clinical outcome of the events fever, arm pain, headache, chills, rash from site to hairline was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Severely Swollen gland left side of face.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Er2613/eie2613) via an unspecified route of administration in the left arm on 30Mar2021 at 09:30 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included COPD (Chronic obstructive pulmonary disease). Concomitant medication were not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 03Apr2021, the patient experienced severely swollen gland on the left side of the face. The adverse event did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient received Cephalexin 500mg, thrice daily for 7 days as the treatment for the reported event. The clinical outcome of the event severely swollen gland on left side of the face was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: Severe stomach cramps for 8 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food, or other products. Concomitant medications included hydrochlorothiazide, quinapril hydrochloride (ACCURETIC) and atorvastatin (MANUFACTURER UNKNOWN), both taken for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced severe stomach cramps for 8 hours. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe stomach cramps was resolved on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Tenderness at injection site started several hours after injection; Minor swelling at injection site started several hours after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 06Apr2021 at 10:45 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 13:00, the patient experienced tenderness and minor swelling at injection site which started several hours after injection. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tenderness and minor swelling at injection site which started several hours after injection were recovered on 08Apr2021.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Headache; fever; chills; This is a spontaneous report from a contactable consumer. An adult male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 07Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown if the patient had received any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced headache, fever and chills. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was unknown if the patient had received any treatment for the reported events. The clinical outcome of the events headache, fever and chills was recovering at the time of this report.   No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity, Sluggishness
Clinical narrative: sore left upper arm; sluggish feeling; tired; a little bit achy all over; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 14:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and allergies. Concomitant medications included loratadine (CLARITIN), budesonide (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN, strength: 125 mcg) for unknown indication and on unknown date within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 Within 4-6 hours of vaccination, the patient experienced sluggish feeling, tired and a little bit achy all over. On 08Apr2021 at 18:15 within 16 hours the next morning, the patient experienced sore left upper arm.  No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sluggish feeling, tired, a little bit achy all over and sore left upper arm was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Severe arm pain; Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included that the patient was diagnosed with COVID-19 on an unknown date. Concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received the unspecified vaccine within four weeks prior to the COVID-19 vaccine. On an unknown date in 2021, the patient experienced severe arm pain, fever and fatigue. The clinical outcome of the events of severe arm pain, fever and fatigue was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Nausea
Clinical narrative: 100.3 fever; Chills; Joint pain; Nausea; Exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic to penicillin. Concomitant medication included FLO GUMMIES, taken for unknown indication and from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 00:00, the patient experienced 100.3 fever, chills, joint pain, nausea and exhaustion. The patient did not receive any treatment for the events. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. On 07Apr2021, patient body temperature was measured and result was 100.3(unspecified units). The clinical outcome of the events 100.3 fever, chills, joint pain, nausea and exhaustion were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 100.3 fever; Chills; Joint pain; Nausea; Exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic to penicillin. Concomitant medication included FLO GUMMIES, taken for unknown indication and from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 00:00, the patient experienced 100.3 fever, chills, joint pain, nausea and exhaustion. The patient did not receive any treatment for the events. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. On 07Apr2021, patient body temperature was measured and result was 100.3(unspecified units). The clinical outcome of the events 100.3 fever, chills, joint pain, nausea and exhaustion were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Wheezing
Clinical narrative: it becomes hard to breather much quicker and lasts much longer. Patient can almost feel it in throat and chest that it's harder to breathe, and toward the end of a long exhale, it sounds as though wheezing.; it becomes hard to breather much quicker and lasts much longer. Patient can almost feel it in throat and chest that it's harder to breathe, and toward the end of a long exhale, it sounds as though wheezing.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 03Apr2021 at 16:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy, penicillin allergy. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously took amoxicillin (MANAFACTURER UNKNOWN), E-mycin (MANAFACTURER UNKNOWN), cefaclor (CECLOR), amoxicillin; potassium clavulanate (AUGMENTIN) all from an unknown date for an unspecified indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 08:00 the patient experienced whenever exerting himself, such as lifting weights or doing cardio, it becomes hard to breather much quicker and lasts much longer. Can almost feel it in throat and chest that was harder to breathe, and toward the end of a long exhale, it sounded as though he was wheezing. It was beyond normal exertion. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events breathing difficult, wheezing was recovered with sequelae on an unspecified date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Paraesthesia, Somnolence
Clinical narrative: Tingling in arms and feet; Sleepiness; Muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 (at the age of 49-year-old) as a single dose, 0.3 mL for COVID-19 immunisation. Medical history included mitral valve prolapse and calcium deposits. The patient had not received other medications within two weeks of vaccination. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced tingling in arms and feet, muscle soreness and sleepiness. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingling in arms and feet, muscle soreness and sleepiness was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cold sweat, Dizziness, Dysphagia, Feeling hot
Clinical narrative: Hives around my injection site; Cold sweat; My tongue went numb and temporarily enlarged; My tongue went numb and temporarily enlarged; Throat swelled; Difficulty swallowing; Grew overwhelmingly hot; Weak; Tingly on the left side of my body; Dizzy; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) dose 1 via an unspecified route of administration, administered in the left arm on 06Apr2021 at 16:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (Mild arthritis), haematuria from an unknown date and unknown if ongoing (Mild (rare) acute hematuria), factor V leiden mutation from an unknown date and unknown if ongoing (Heterozygous for FACTOR V clotting disorder), anaemia from an unknown date and unknown if ongoing (occasional history of anemia). Concomitant medications included levonorgestrel (KYLEENA) taken for an unspecified indication, start and stop date were not reported; vitamin D for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient reported, "5 minutes after receiving the vaccine, I grew overwhelmingly hot, but this subsided. An hour later, I broke into a cold sweat, my tongue went numb and temporarily enlarged, my throat swelled and I had difficulty swallowing. Near the 2 hour mark, I grew considerably weak, tingly on the left side of my body, and dizzy. The swelling and numbness subsided within 5 hours and emergency doses of steroids and Benadryl. The next morning, I had hives around my injection site." Treatment for the events included prednisone, diphenhydramine (BENADRYL), and saline solution. The patient recovered from the events, grew overwhelmingly hot, tongue went numb and temporarily enlarged, and throat swelled. The patient was recovering from the events, cold sweat, difficulty swallowing, weak, tingly on the left side of my body, and dizzy. The outcome of the event, hives around my injection site was unknown.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia, Pharyngeal swelling, Swollen tongue, Vaccination site urticaria
Clinical narrative: Hives around my injection site; Cold sweat; My tongue went numb and temporarily enlarged; My tongue went numb and temporarily enlarged; Throat swelled; Difficulty swallowing; Grew overwhelmingly hot; Weak; Tingly on the left side of my body; Dizzy; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) dose 1 via an unspecified route of administration, administered in the left arm on 06Apr2021 at 16:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (Mild arthritis), haematuria from an unknown date and unknown if ongoing (Mild (rare) acute hematuria), factor V leiden mutation from an unknown date and unknown if ongoing (Heterozygous for FACTOR V clotting disorder), anaemia from an unknown date and unknown if ongoing (occasional history of anemia). Concomitant medications included levonorgestrel (KYLEENA) taken for an unspecified indication, start and stop date were not reported; vitamin D for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient reported, "5 minutes after receiving the vaccine, I grew overwhelmingly hot, but this subsided. An hour later, I broke into a cold sweat, my tongue went numb and temporarily enlarged, my throat swelled and I had difficulty swallowing. Near the 2 hour mark, I grew considerably weak, tingly on the left side of my body, and dizzy. The swelling and numbness subsided within 5 hours and emergency doses of steroids and Benadryl. The next morning, I had hives around my injection site." Treatment for the events included prednisone, diphenhydramine (BENADRYL), and saline solution. The patient recovered from the events, grew overwhelmingly hot, tongue went numb and temporarily enlarged, and throat swelled. The patient was recovering from the events, cold sweat, difficulty swallowing, weak, tingly on the left side of my body, and dizzy. The outcome of the event, hives around my injection site was unknown.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Chills; Exhaustion; Bad headache; This is a spontaneous report from a contactable consumer, the parent. A 23-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on 07Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced chills, exhaustion and bad headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills, exhaustion and bad headache were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: This is a spontaneous report from a contactable healthcare professional, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 07Apr2021 at 09:15 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications included fexofenadine hydrochloride (manufacturer-ALLEGRA), mometasone furoate (manufacturer-NASONEX) and ketotifen fumarate (manufacturer- ZADITOR eye drops) all from unknown dates for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EL3247) via an unspecified route of administration in the left arm on 17Mar2021 at 09:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 the patient experienced achy back (woke up in the morning with achy back). Therapeutic measures were not taken as a result of the adverse events. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event achy back (woke up in the morning with achy back) was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Sore arm; Itchy 3"x2" rash around location of injection; Itchy 3"x2" rash around location of injection; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8730) via an unspecified route of administration in the left arm on 26Mar2021 at 10:15 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took macrobid and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, one week post vaccination, the patient experienced sore arm for 3 days and itchy 3"x2" rash around the location of injection which lasted for about 4 to 5 days. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events sore arm was resolved on 05Apr2021 and itchy rash around the location of injection was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Headache, Pain in extremity
Clinical narrative: Sick to stomach; Pain in arm; Headache; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 12:45 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19). Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 13:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. He also received piperacillin sodium; tazobactam sodium (ZOSYN) and promethazine (PHENERGAN), on an unknown date for an unspecified indication and experienced drug allergy. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 14:00, the patient experienced sick to stomach, pain in arm, headache and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of sick to stomach, pain in arm, headache and tiredness was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: The arm was sore a little bit; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Apr2021 at 09:00 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety attack and COVID-19. The patient did not have a history of allergies to food, medications, or other products. Concomitant medications included aripiprazole 20 milligrams (MANUFACTURER UNKNOWN) and sertraline unknown dose in mg (MANUFACTURER UNKNOWN) for an unknown indication and from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 09:00, the patient experienced arm was sore a little bit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the event. The clinical outcome of the event arm was sore a little bit was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Extreme fatigue; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6199) via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included slight sensitivity to histamines. Concomitant medications included colecalciferol (VITAMIN D), ascorbic acid (VITAMIN C), tocopheryl acetate (VITAMIN E), cod-liver oil (FISH OIL) and zinc (MANUFACTURER UNKNOWN) for unknown indication and on unknown date within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 07:00, the patient experienced extreme fatigue and slight headache. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events extreme fatigue and slight headache was recovered in 2021, at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in left ear; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 06Apr2021 at 09:15 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. Patient has known allergy to sulfa meds. Concomitant medications included topiramate (TOPAMAX), buspirone hydrochloride (BUSPAR) and iron supplements (IRON) all for unknown indication from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:00, the patient experienced ringing in left ear. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ringing in left ear was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspnoea, Fatigue, Headache
Clinical narrative: Fever of 99.9 degrees; Chills; Mild headache; Aches; Arm pain; Fatigue; Mild shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 62-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 07Apr2021 at 11:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and COVID - 19 infection. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN) for unknown indication, from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 17Mar2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:30 the patient experienced fever of 99.9 degrees Fahrenheit, chills, mild headache, aches, arm pain, fatigue and mild shortness of breath. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown, if the therapeutic measures were taken as a result of reported events. The clinical outcome of the events fever of 99.9 degrees Fahrenheit, chills, mild headache, aches, arm pain, fatigue and mild shortness of breath was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever of 99.9 degrees; Chills; Mild headache; Aches; Arm pain; Fatigue; Mild shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 62-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 07Apr2021 at 11:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and COVID - 19 infection. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN) for unknown indication, from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the right arm on 17Mar2021 at 10:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 19:30 the patient experienced fever of 99.9 degrees Fahrenheit, chills, mild headache, aches, arm pain, fatigue and mild shortness of breath. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown, if the therapeutic measures were taken as a result of reported events. The clinical outcome of the events fever of 99.9 degrees Fahrenheit, chills, mild headache, aches, arm pain, fatigue and mild shortness of breath was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: High heart rate I believe 2 days after vaccine. My heart rate was steadily high for at least 30 minutes I couldnt get it to slow.; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 25Mar2021 as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021, the patient experienced high heart rate 2 days after vaccine, the patient's heart rate was steadily high for at least 30 minutes and couldn't get it to slow. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event high heart rate was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine, Pain in extremity
Clinical narrative: Aside from sore arm; Fatigue; I had a severe migraine.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 12Feb2021 at 13:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included drospirenone, ethinylestradiol (GIANVI) and esomeprazole magnesium (MANUFACTURER UNKNOWN) both for unknown indication from unknown dates. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Feb2021 at 13:00, the patient experienced aside from sore arm and fatigue. Aside from sore arm and fatigue the patient had severe migraine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with migraine specific medicines (unspecified) and ibuprofen (ADVIL). The clinical outcome of events sore arm, fatigue and severe migraine was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.